AstraZeneca Said Preliminary Data from a Trial It Conducted on Its COVID-19 Shot, ... - Latest Tweet by Reuters

AstraZeneca said preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, including Beta, Delta, Alpha and Gamma, when given as a third booster dose https://t.co/WO5K0s9ebA— Reuters (@Reuters) January 13, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)